1. Home
  2. AURA vs BWMN Comparison

AURA vs BWMN Comparison

Compare AURA & BWMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • BWMN
  • Stock Information
  • Founded
  • AURA 2007
  • BWMN 1995
  • Country
  • AURA United States
  • BWMN United States
  • Employees
  • AURA N/A
  • BWMN N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • BWMN Military/Government/Technical
  • Sector
  • AURA Health Care
  • BWMN Consumer Discretionary
  • Exchange
  • AURA Nasdaq
  • BWMN Nasdaq
  • Market Cap
  • AURA 370.1M
  • BWMN 368.1M
  • IPO Year
  • AURA 2021
  • BWMN 2021
  • Fundamental
  • Price
  • AURA $5.36
  • BWMN $22.23
  • Analyst Decision
  • AURA Strong Buy
  • BWMN Strong Buy
  • Analyst Count
  • AURA 4
  • BWMN 3
  • Target Price
  • AURA $22.75
  • BWMN $33.83
  • AVG Volume (30 Days)
  • AURA 482.7K
  • BWMN 134.0K
  • Earning Date
  • AURA 05-08-2025
  • BWMN 05-06-2025
  • Dividend Yield
  • AURA N/A
  • BWMN N/A
  • EPS Growth
  • AURA N/A
  • BWMN N/A
  • EPS
  • AURA N/A
  • BWMN 0.17
  • Revenue
  • AURA N/A
  • BWMN $426,564,000.00
  • Revenue This Year
  • AURA N/A
  • BWMN $14.06
  • Revenue Next Year
  • AURA N/A
  • BWMN $5.47
  • P/E Ratio
  • AURA N/A
  • BWMN $130.76
  • Revenue Growth
  • AURA N/A
  • BWMN 23.19
  • 52 Week Low
  • AURA $4.84
  • BWMN $17.90
  • 52 Week High
  • AURA $12.38
  • BWMN $36.65
  • Technical
  • Relative Strength Index (RSI)
  • AURA 37.19
  • BWMN 50.11
  • Support Level
  • AURA $4.84
  • BWMN $21.51
  • Resistance Level
  • AURA $5.82
  • BWMN $22.76
  • Average True Range (ATR)
  • AURA 0.48
  • BWMN 1.26
  • MACD
  • AURA 0.03
  • BWMN -0.01
  • Stochastic Oscillator
  • AURA 32.20
  • BWMN 66.56

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About BWMN Bowman Consulting Group Ltd.

Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape, and Architecture/Planning.

Share on Social Networks: